Last reviewed · How we verify
Prilocaine HCl % 2 injectable solution — Competitive Intelligence Brief
marketed
Local anesthetic (amide class)
Voltage-gated sodium channels
Anesthesia
Small molecule
Live · refreshed every 30 min
Target snapshot
Prilocaine HCl % 2 injectable solution (Prilocaine HCl % 2 injectable solution) — Bozyaka Training and Research Hospital. Prilocaine HCl is a local anesthetic that blocks sodium channels in nerve cell membranes, preventing the initiation and conduction of nerve impulses.
Comparator set (6 drugs)
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Prilocaine HCl % 2 injectable solution TARGET | Prilocaine HCl % 2 injectable solution | Bozyaka Training and Research Hospital | marketed | Local anesthetic (amide class) | Voltage-gated sodium channels | |
| Bupivacaine 0.5 % with Epinephrine | Bupivacaine 0.5 % with Epinephrine | Holy Cross Hospital, Florida | marketed | Local anesthetic with vasopressor | Voltage-gated sodium channels | |
| lidocaine + epinephrine 1:100,000 | lidocaine + epinephrine 1:100,000 | Weill Medical College of Cornell University | marketed | Local anesthetic with vasoconstrictor | Voltage-gated sodium channels (lidocaine); alpha-1 and beta-1 adrenergic receptors (epinephrine) | |
| Ropivacaine + saline solution | Ropivacaine + saline solution | Federal University of Minas Gerais | marketed | Local anesthetic (amide class) | Voltage-gated sodium channels | |
| Bupivacaine Spinal 0,5% Heavy - titration | Bupivacaine Spinal 0,5% Heavy - titration | Centre of Postgraduate Medical Education | marketed | Local anesthetic (amide class) | Voltage-gated sodium channels (Nav) | |
| LMX 4 Topical Cream | LMX 4 Topical Cream | Rush University Medical Center | marketed | Local anesthetic | Voltage-gated sodium channels | |
| blind injection of Mepivacaine | blind injection of Mepivacaine | Complejo Hospitalario Universitario de Granada | marketed | Local anesthetic (amide class) | Voltage-gated sodium channels |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Local anesthetic (amide class) class)
- Ain Shams University · 2 drugs in this class
- Başakşehir Çam & Sakura City Hospital · 2 drugs in this class
- TriHealth Inc. · 2 drugs in this class
- Centre of Postgraduate Medical Education · 2 drugs in this class
- Bozyaka Training and Research Hospital · 2 drugs in this class
- Complejo Hospitalario Universitario de Granada · 1 drug in this class
- Clinique Saint-Jean, Bruxelles · 1 drug in this class
- Hospital Clínico Universitario de Valencia · 1 drug in this class
- Fundacion Clinica Valle del Lili · 1 drug in this class
- Federal University of Minas Gerais · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Prilocaine HCl % 2 injectable solution CI watch — RSS
- Prilocaine HCl % 2 injectable solution CI watch — Atom
- Prilocaine HCl % 2 injectable solution CI watch — JSON
- Prilocaine HCl % 2 injectable solution alone — RSS
- Whole Local anesthetic (amide class) class — RSS
Cite this brief
Drug Landscape (2026). Prilocaine HCl % 2 injectable solution — Competitive Intelligence Brief. https://druglandscape.com/ci/prilocaine-hcl-2-injectable-solution. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing